These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. The Use and Misuse of Proton Pump Inhibitors: An Opportunity for Deprescribing. Dharmarajan TS J Am Med Dir Assoc; 2021 Jan; 22(1):15-22. PubMed ID: 33321078 [TBL] [Abstract][Full Text] [Related]
30. Evaluation of use of proton pump inhibitors in Greece. Ntaios G; Chatzinikolaou A; Kaiafa G; Savopoulos C; Hatzitolios A; Karamitsos D Eur J Intern Med; 2009 Mar; 20(2):171-3. PubMed ID: 19327607 [TBL] [Abstract][Full Text] [Related]
31. Helicobacter pylori and nonsteroidal anti-inflammatory drugs: interaction with proton pump inhibitor therapy for prevention of nonsteroidal anti-inflammatory drug ulcers and ulcer complications--future research needs. Graham DY Am J Med; 2001 Jan; 110(1A):58S-61S. PubMed ID: 11166000 [TBL] [Abstract][Full Text] [Related]
32. [Current use of proton pump inhibitors and when to limit, stop or not start treatment]. Helgadottir H; Bjornsson ES Laeknabladid; 2023 Jul; 109(708):338-345. PubMed ID: 37378651 [TBL] [Abstract][Full Text] [Related]
33. Results of an intervention in an academic Internal Medicine Clinic to continue, step-down, or discontinue proton pump inhibitor therapy related to a tennessee medicaid formulary change. Ramser KL; Sprabery LR; Hamann GL; George CM; Will A J Manag Care Pharm; 2009 May; 15(4):344-50. PubMed ID: 19422274 [TBL] [Abstract][Full Text] [Related]
34. The Indications, Applications, and Risks of Proton Pump Inhibitors. Mössner J Dtsch Arztebl Int; 2016 Jul; 113(27-28):477-83. PubMed ID: 27476707 [TBL] [Abstract][Full Text] [Related]
35. Management of NSAID-induced gastrointestinal toxicity: focus on proton pump inhibitors. Lazzaroni M; Porro GB Drugs; 2009; 69(1):51-69. PubMed ID: 19192936 [TBL] [Abstract][Full Text] [Related]
36. [Peptic ulcer and Helicobacter pyrlori. Results and consequences of its eradication]. Ballesteros-Amozurrutia MA Rev Gastroenterol Mex; 2000; 65(4 Suppl 2):41-9. PubMed ID: 11464621 [TBL] [Abstract][Full Text] [Related]
37. Rabeprazole for the treatment of acid-related disorders. Marelli S; Pace F Expert Rev Gastroenterol Hepatol; 2012 Aug; 6(4):423-35. PubMed ID: 22928894 [TBL] [Abstract][Full Text] [Related]
38. Proton pump inhibitors for preventing non-steroidal anti-inflammatory drug induced gastrointestinal toxicity: a systematic review. Yang M; He M; Zhao M; Zou B; Liu J; Luo LM; Li QL; He JH; Lei PG Curr Med Res Opin; 2017 Jun; 33(6):973-980. PubMed ID: 28076696 [TBL] [Abstract][Full Text] [Related]
39. [Evidence and uncertainties on the clinical use of proton pump inhibitors]. de Prados CM Gastroenterol Hepatol; 2010 May; 33 Suppl 1():5-10. PubMed ID: 20728783 [TBL] [Abstract][Full Text] [Related]